Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?-Reference-Cited by-同舟云学术

Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?

Published:2017-04-18 Issue:1 Volume:8 Page:
ISSN:1757-6512
Container-title:Stem Cell Research & Therapy
language:en
Short-container-title:Stem Cell Res Ther

Author:

Lanthier Nicolas,Lin-Marq Nathalie,Rubbia-Brandt Laura,Clément Sophie,Goossens Nicolas,Spahr Laurent

Funder

Clinical Research Center, Hôpitaux Universitaires de Genève

Louis-Jeantet Foundation

FLAGS (Foundation for Liver and Gut Studies)

Fondation Saint-Luc

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13287-017-0541-2.pdf

Reference25 articles.

1. Mathurin P. Therapeutic management of alcoholic hepatitis. Clin Res Hepatol Gastroenterol. 2015;39 Suppl 1:S41–5.

2. Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:505–12.

3. Singh V, Sharma AK, Narasimhan RL, Bhalla A, Sharma N, Sharma R. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. Am J Gastroenterol. 2014;109:1417–23.

4. Lyra AC, Soares MB, da Silva LF, Braga EL, Oliveira SA, Fortes MF, et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol. 2010;22:33–42.

5. Salama H, Zekri AR, Bahnassy AA, Medhat E, Halim HA, Ahmed OS, et al. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol. 2010;16:5297–305.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicles are key players in mesenchymal stem cells’ dual potential to regenerate and modulate the immune system;Advanced Drug Delivery Reviews;2024-04

2. Manipulating HGF signaling reshapes the cirrhotic liver niche and fills a therapeutic gap in regeneration mediated by transplanted stem cells;Experimental Cell Research;2024-01

3. RNA therapeutics for regenerative medicine;Progress in Molecular Biology and Translational Science;2024

4. Arouse potential stemness: Intrinsic and acquired stem cell therapeutic strategies for advanced liver diseases;Cell Insight;2023-10

5. Isolation, culture, and delivery considerations for the use of mesenchymal stem cells in potential therapies for acute liver failure;Frontiers in Immunology;2023-09-07